Nothing Special   »   [go: up one dir, main page]

ES2087291T3 - Nuevo uso de bambuterol. - Google Patents

Nuevo uso de bambuterol.

Info

Publication number
ES2087291T3
ES2087291T3 ES91906760T ES91906760T ES2087291T3 ES 2087291 T3 ES2087291 T3 ES 2087291T3 ES 91906760 T ES91906760 T ES 91906760T ES 91906760 T ES91906760 T ES 91906760T ES 2087291 T3 ES2087291 T3 ES 2087291T3
Authority
ES
Spain
Prior art keywords
bambuterol
new use
manufacture
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91906760T
Other languages
English (en)
Inventor
Carl-Axel Bauer
Leif Ke Svensson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Application granted granted Critical
Publication of ES2087291T3 publication Critical patent/ES2087291T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE PRESENTA EL USO DEL BAMBUTEROL O DE UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO PARA LA FABRICACION DE UN PREPARADO FARMACEUTICO QUE TIENE EFECTOS EN LA REDUCCION DE LOS LIPIDOS.
ES91906760T 1990-03-16 1991-03-14 Nuevo uso de bambuterol. Expired - Lifetime ES2087291T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9000948A SE9000948D0 (sv) 1990-03-16 1990-03-16 New use

Publications (1)

Publication Number Publication Date
ES2087291T3 true ES2087291T3 (es) 1996-07-16

Family

ID=20378886

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91906760T Expired - Lifetime ES2087291T3 (es) 1990-03-16 1991-03-14 Nuevo uso de bambuterol.

Country Status (28)

Country Link
US (2) US5837727A (es)
EP (1) EP0521967B1 (es)
JP (1) JP3081640B2 (es)
KR (1) KR100194995B1 (es)
AT (1) ATE138570T1 (es)
AU (1) AU653149B2 (es)
CA (1) CA2077762C (es)
CZ (1) CZ279308B6 (es)
DE (1) DE69119896T2 (es)
DK (1) DK0521967T3 (es)
EG (1) EG19645A (es)
ES (1) ES2087291T3 (es)
GR (1) GR3020700T3 (es)
HK (1) HK52197A (es)
HU (1) HU211998B (es)
IE (1) IE80668B1 (es)
IL (1) IL97509A (es)
LT (1) LT3734B (es)
LV (1) LV10917B (es)
MY (1) MY114218A (es)
NZ (1) NZ237279A (es)
PT (1) PT97052B (es)
RU (1) RU2093153C1 (es)
SE (1) SE9000948D0 (es)
SG (1) SG64895A1 (es)
SK (1) SK278815B6 (es)
WO (1) WO1991013615A1 (es)
ZA (1) ZA911452B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use
US6459316B1 (en) * 2000-12-08 2002-10-01 Intel Corporation Flip flop circuit
AU2002351732A1 (en) * 2001-12-14 2003-06-30 Novo Nordisk A/S Compositions decreasing activity of hormone-sensitive lipase
US7495028B2 (en) 2002-08-08 2009-02-24 Wen Tan R-bambuterol, its preparation and therapeutic uses
EP2002831A1 (en) * 2002-08-08 2008-12-17 Wen Tan R-Bambuterol, its preparation and therapeutic uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043807B1 (en) * 1980-07-09 1984-05-30 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
US4472436A (en) * 1982-12-06 1984-09-18 Neo-Bionics, Inc. Increasing HDL-cholesterol levels with phenylethylamine derivatives
EP0244062A3 (en) * 1986-03-03 1990-06-20 Beecham Group Plc Use of aryl ethanol amine derivatives in the treatment of atherosclerosis
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use

Also Published As

Publication number Publication date
IL97509A (en) 1995-12-31
PT97052A (pt) 1991-10-31
DK0521967T3 (da) 1996-09-09
NZ237279A (en) 1993-08-26
CA2077762C (en) 2001-06-12
DE69119896T2 (de) 1996-10-10
GR3020700T3 (en) 1996-10-31
LV10917B (en) 1996-04-20
EP0521967A1 (en) 1993-01-13
AU653149B2 (en) 1994-09-22
SG64895A1 (en) 2000-01-25
SK278815B6 (sk) 1998-03-04
US6034123A (en) 2000-03-07
HK52197A (en) 1997-05-02
JP3081640B2 (ja) 2000-08-28
MY114218A (en) 2002-09-30
EG19645A (en) 1995-09-30
LTIP1735A (en) 1995-07-25
HU211998B (en) 1996-01-29
CS9100681A2 (en) 1991-10-15
KR100194995B1 (ko) 1999-06-15
EP0521967B1 (en) 1996-05-29
JPH05504971A (ja) 1993-07-29
AU7569191A (en) 1991-10-10
IL97509A0 (en) 1992-06-21
SE9000948D0 (sv) 1990-03-16
WO1991013615A1 (en) 1991-09-19
US5837727A (en) 1998-11-17
HU9202958D0 (en) 1992-12-28
RU2093153C1 (ru) 1997-10-20
HUT61461A (en) 1993-01-28
LT3734B (en) 1996-02-26
CA2077762A1 (en) 1991-09-17
IE80668B1 (en) 1998-11-18
DE69119896D1 (de) 1996-07-04
LV10917A (lv) 1995-12-20
ZA911452B (en) 1991-11-27
CZ279308B6 (cs) 1995-04-12
ATE138570T1 (de) 1996-06-15
PT97052B (pt) 1998-07-31
IE910862A1 (en) 1991-09-25

Similar Documents

Publication Publication Date Title
MX9101175A (es) Composicion farmaceutica para administracion nasal
IT1133025B (it) Nuovi eteri per uso farmaceutico e procedimento per la loro preparazione
AR231987A1 (es) Procedimiento para preparar derivados farmaceuticos de pirrolo-2,1-c 1,4 tiazepin-1,5-diona y compuesto intermediario para uso exclusivo en el mismo
NO910935D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive c-bundne pyrazol-derivater.
FI883923A (fi) Foerfarande och anordning i samband med spetsdragningen av en pappersbana.
FI922806A (fi) Substituerade 4-fenyl-4 -piperidinkarboxamider med baode lokalbedoevande och smaertstillande effekt samt foerfaranden foer deras framstaellning.
NO911065D0 (no) Fremgangsmaate for fremstilling av lipopeptidderivater.
IT1143047B (it) Composti diazepinici per uso farmaceutico e loro procedimento di preparazione
NO900919D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske etere.
ES2087291T3 (es) Nuevo uso de bambuterol.
IT8521945A0 (it) 2-piridilcarbossammide particolarmente per uso farmaceutico.
NO306381B1 (no) Farmasöytisk ampulle
NO913187D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.
BR9105405A (pt) Derivados de cefalosporina,preparado farmaceutico,processo para a preparacao de compostos e uso
IT9020160A0 (it) Derivati 1,5-benzotiazepinonici, loro preparazione e uso farmaceutico
JO1692B1 (en) Use of a pharmaceutically acceptable salt
SE9304236D0 (sv) New use
IT9068059A0 (it) Preparato antiinfiammatorio ad uso oftalmico.
FI932332A0 (fi) Nya pyridobenzoindolderivat, deras framstaellning och dessa innehaollande farmaceutiska preparat
SE9000288D0 (sv) New use
DK171089D0 (da) Anvendelse af tetrazolderivater til fremstilling af laegemidler
IT1115788B (it) 5-fenil-2-ossazolo carbossimmidammi di per uso farmaceutico
NO922645D0 (no) Anvendelse av lokale anestesimidler for fremstilling av farmasoeytiske preparater for iontoforese
DK204190D0 (da) Farmaceutisk praeparat
DK50288A (da) Anvendelse af et benzo-c-phenanthridinalkaloid til fremstilling af et farmaceutisk middel

Legal Events

Date Code Title Description
FC2A Grant refused

Effective date: 19930618

FG2A Definitive protection

Ref document number: 0521967

Country of ref document: ES